文献速递消化道肿瘤与早癌

WNT驱动免疫逃逸促进BRAF突变结直肠癌恶性转化

WNT-Driven Immune Evasion Promotes Malignant Transformation of BRAF-Mutant Colorectal Cancer.
PubMed 文献 · Gastroenterology · 2026-08-18

该研究利用多种基因工程小鼠模型和类器官移植模型,探讨WNT通路激活在BRAF突变微卫星稳定(MSS)结直肠癌恶性转化中的作用。研究发现,通过APC或CTNNB1突变(而非RNF43缺失)激活WNT通路是肿瘤起始所必需,WNT激活抑制CCL20表达、重塑免疫微环境并促进免疫逃逸,从而驱动恶性进展。

要点

  • WNT通路激活(APC或CTNNB1突变)是BRAF突变MSS结直肠癌肿瘤起始的关键。
  • WNT激活抑制CCL20表达并重塑免疫微环境,促进免疫抑制性髓系细胞和T细胞状态改变。
  • WNT信号通路可作为该侵袭性结直肠癌亚型的潜在治疗靶点。

核心结论

  • WNT通路激活通过 enabling 免疫逃逸,是BRAF突变MSS结直肠癌恶性转化的关键决定因素。

研究设计与样本

  • 研究构建了多种BRAF突变MSS结直肠癌基因工程小鼠模型及配套的类器官移植模型。

主要发现

  • 通过APC或CTNNB1突变激活WNT通路(而非RNF43缺失)是BRAF突变结直肠癌模型肿瘤起始所必需。
  • WNT激活诱导分子亚型转变并抑制免疫应答通路。
  • WNT信号抑制C-C趋化因子配体20(CCL20)表达,并通过促进免疫抑制性髓系细胞群和改变T细胞状态重塑肿瘤微环境。
  • 功能实验表明WNT激活在免疫健全环境中增强肿瘤进展,提示免疫逃逸是恶性进展的关键驱动因素。

临床怎么用

  • WNT信号通路是BRAF突变MSS结直肠癌中肿瘤-免疫相互作用的中心调节因子,可作为潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: BRAF-mutant colorectal cancer (CRC) is a clinically aggressive subtype arising from the serrated pathway and is associated with poor prognosis and therapy resistance. The mechanisms driving malignant transformation in microsatellite-stable (MSS) BRAF-mutant CRC remain incompletely understood. We aimed to define the role of WNT pathway activation in serrated CRC progression and tumor-immune interactions. METHODS: We generated multiple genetically engineered mouse models of BRAF-mutant MSS CRC and complementary organoid-based transplantation models. Genetic alterations in WNT pathway components were functionally interrogated. Tumor development and immune microenvironment remodeling were analyzed using bulk RNA sequencing, single-cell RNA sequencing, Cellular Indexing of Transcriptomes and Epitopes by Sequencing, and functional in vivo assays. RESULTS: WNT pathway activation via APC or CTNNB1 mutations, but not RNF43 loss, was required for tumor initiation in BRAF-mutant CRC models. WNT activation induced a molecular subtype shift and suppressed immune response pathways. Mechanistically, WNT signaling suppressed C-C motif chemokine ligand 20 expression and remodeled the tumor microenvironment by promoting immunosuppressive myeloid populations and altering T-cell states. Functional assays demonstrated that WNT activation enhances tumor progression in immunocompetent settings, indicating immune evasion as a key driver of malignant progression. CONCLUSIONS: WNT pathway activation is a critical determinant of malignant transformation in BRAF-mutant MSS CRC by enabling immune escape. These findings identify WNT signaling as a central regulator of tumor-immune interactions and a potential therapeutic target in this aggressive CRC subtype.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Mastel M, Martinez AG, Pozza U, et al. WNT-Driven Immune Evasion Promotes Malignant Transformation of BRAF-Mutant Colorectal Cancer. Gastroenterology. 2026. PMID: 42612882. doi:10.1053/j.gastro.2026.07.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。